CARB-X Places $22 Million Bet on Affinivax Staph Vaccine
Biospace,
Less than two months after bacterial vaccine company Affinivax ’s Series C financing, the company is getting a $22 million…
Less than two months after bacterial vaccine company Affinivax ’s Series C financing, the company is getting a $22 million…
https://www.infectioncontroltoday.com/sites/all/themes/penton_subtheme_infectioncontroltoday/images/logos/footer.png Data…